Welcome to
Sysmex Flow Cytometry Germany!

For ordering please make sure you are in your local shop.
If you are from Germany then please continue.
Otherwise please go to your country.

Go to my country Continue

Article successfully added.

CyFlow™ CD53 FITC

CyFlow™ CD53 FITC
Antigen: CD53
Alternative Name: TSPAN2
Clone: MEM-53
Application: Flow cytometry
Format/Fluorochrome: FITC
Laser: Blue
Target Species: Human
Field of Interest: Immunophenotyping
Species of Origin: Mouse
Regulatory Status: RUO
Clonality: monoclonal
Emission Maximum: 518 nm
Excitation Maximum: 490 to 495 nm
Isotype: IgG1
Order number: AC821626

For Research Use Only
Not for use in diagnostic or therapeutic procedures.

 180.00 EUR*

Prices net excl. VAT, plus applicable shipping costs

Quantity 100 tests Volume 2 Immunogen Leukocytes of a patient suffering from LGL-type... more
CyFlow™ CD53 FITC
Quantity100 tests
Volume2
ImmunogenLeukocytes of a patient suffering from LGL-type leukemia
Background InformationCD53 is a tetraspanin family transmembrane glycoprotein expressed in the lymphoid-myeloid lineage. This molecule has been reported to form complexes with other leukocyte surface proteins such as CD2, CD19, CD21, MHC II, VLA-4 or tetraspanins CD37, CD81 and CD82, thus probably modulating various signaling processes. CD53 is involved in radioresistancy of tumor cells and its triggering has anti-apoptotic effect. In thymus, CD53 is up-regulated in response to positive selection signals during T cell development, and is strongly expressed upon macrophage exposure to bacterial lipopolysaccharide, whereas stimulation of neutrophils results in down-regulation of CD53 expression.
UsageThe reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 20·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Specific References

| Bazil V, Horejsi V, Baudys M, Kristofova H, Strominger JL, Kostka W, Hilgert I: Biochemical characterization of a soluble form of the 53‑kDa monocyte surface antigen. Eur·J·Immunol. 1986·Dec; 16(12):1583‑9. <·PMID:·3493149·> | Knapp W, Dorken B, Gilks W, Rieber EP, Schmidt RE, Stein H, von dem Borne AEGK (Eds): Leucocyte Typing IV. Oxford·University·Press,·Oxford. 1989; 1‑1820. <·NLM·ID:·8914679·> | Angelisová P, Vlcek C, Stefanova I, Lipoldova M, Horejsi V: The human leucocyte surface antigen CD53 is a protein structurally similar to the CD37 and MRC OX‑44 antigens.. Immunogenetics. 1990; 32(4):281‑5. <·PMID:·1700763·> | Doussis IA, Gatter KC, Mason DY: CD68 reactivity of non‑macrophage derived tumours in cytological specimens. J·Clin·Pathol. 1993·Apr; 46(4):334‑6. <·PMID:·7684403·> | Olweus J, Lund-Johansen F, Horejsi V: CD53, a protein with four membrane‑spanning domains, mediates signal transduction in human monocytes and B cells. J·Immunol. 1993·Jul·15; 151(2):707‑16. <·PMID:·8335905·> | Olweus J, Lund-Johansen F, Horejsi V: CD53, a protein with four membrane‑spanning domains, mediates signal transduction in human monocytes and B cells. J·Immunol. 1993·Jul·15; 151(2):707‑16. <·PMID:·8335905·> | Rasmussen AM, Blomhoff HK, Stokke T, Horejsi V, Smeland EB: Cross‑linking of CD53 promotes activation of resting human B lymphocytes. J·Immunol. 1994·Dec·1; 153(11):4997‑5007. <·PMID:·7963560·> | Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S: Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J·Immunol. 1996·Oct·1; 157(7):2939‑46. <·PMID:·8816400·> | Mollinedo F, Martín-Martín B, Gajate C, Lazo PA: Physiological activation of human neutrophils down‑regulates CD53 cell surface antigen. J·Leukoc·Biol. 1998·Jun; 63(6):699‑706. <·PMID:·9620662·> | Puls KL, Hogquist KA, Reilly N, Wright MD: CD53, a thymocyte selection marker whose induction requires a lower affinity TCR‑MHC interaction than CD69, but is up‑regulated with slower kinetics. Int·Immunol. 2002·Mar; 14(3):249‑58. <·PMID:·11867561·> | Yunta M, Rodríguez-Barbero A, Arévalo MA, López-Novoa JM, Lazo PA: Induction of DNA synthesis by ligation of the CD53 tetraspanin antigen in primarycultures of mesangial cells. Kidney·Int. 2003·Feb; 63(2):534‑42. <·PMID:·12631118·> | Yunta M, Lazo PA: Apoptosis protection and survival signal by the CD53 tetraspanin antigen. Oncogene. 2003·Feb·27; 22(8):1219‑24. <·PMID:·12606948·> | Kim TR, Yoon JH, Kim YC, Yook YH, Kim IG, Kim YS, Lee H, Paik SG: LPS‑induced CD53 expression: a protection mechanism against oxidative and radiation stress. Mol·Cells. 2004·Feb·29; 17(1):125‑31. <·PMID:·15055538·>